Covered recipient · General Payments record
RACHEL MCCOY
Allopathic & Osteopathic Physicians Pain Medicine Pain Medicine
General Payments · PY2021–2024
$2,131.94
- Reported across 133 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $569.34 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $193.49 | 12 |
| Novo Nordisk AS | $90.86 | 5 |
| Indivior Inc. | $54.42 | 2 |
| Lilly USA, LLC | $51.97 | 3 |
| Amgen Inc. | $45.72 | 3 |
| FORTE BIO-PHARMA LLC | $43.08 | 2 |
| Collegium Pharmaceutical, Inc. | $37.59 | 2 |
| Azurity Pharmaceuticals, Inc. | $21.99 | 1 |
| Actelion Pharmaceuticals US, Inc. | $16.45 | 1 |
| PFIZER INC. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.16 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624307 | CMS |
| ABBVIE INC. | $14.98 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624309 | CMS |
| ABBVIE INC. | $28.99 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624311 | CMS |
| ABBVIE INC. | $18.85 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624313 | CMS |
| ABBVIE INC. | $20.85 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624315 | CMS |
| ABBVIE INC. | $6.76 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624317 | CMS |
| ABBVIE INC. | $24.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624319 | CMS |
| ABBVIE INC. | $4.46 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624321 | CMS |
| ABBVIE INC. | $14.18 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624323 | CMS |
| ABBVIE INC. | $11.82 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624325 | CMS |
| ABBVIE INC. | $12.13 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624327 | CMS |
| ABBVIE INC. | $29.65 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107624329 | CMS |
| Actelion Pharmaceuticals US, Inc. | $16.45 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078897453 | CMS |
| Amgen Inc. | $15.43 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117624594 | CMS |
| Amgen Inc. | $15.35 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117624596 | CMS |
| Amgen Inc. | $14.94 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117624598 | CMS |
| Azurity Pharmaceuticals, Inc. | $21.99 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134019470 | CMS |
| Collegium Pharmaceutical, Inc. | $17.60 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135210129 | CMS |
| Collegium Pharmaceutical, Inc. | $19.99 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135251156 | CMS |
| Forte Bio-Pharma LLC | $19.86 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142424581 | CMS |
| Forte Bio-Pharma LLC | $23.22 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142424583 | CMS |
| Indivior Inc. | $19.77 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562453 | CMS |
| Indivior Inc. | $34.65 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562455 | CMS |
| Lilly USA, LLC | $17.44 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135879105 | CMS |
| Lilly USA, LLC | $16.70 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135928420 | CMS |
| Lilly USA, LLC | $17.83 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135899410 | CMS |
| Novo Nordisk Inc | $18.56 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100610560 | CMS |
| Novo Nordisk Inc | $16.19 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473956 | CMS |
| Novo Nordisk Inc | $18.67 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100483453 | CMS |
| Novo Nordisk Inc | $18.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100256002 | CMS |
| Novo Nordisk Inc | $18.82 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100559865 | CMS |
| PFIZER INC. | $13.77 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131162090 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.